Xponance Inc. Has $73.74 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Xponance Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 145,776 shares of the healthcare conglomerate’s stock after acquiring an additional 3,470 shares during the quarter. UnitedHealth Group accounts for 0.7% of Xponance Inc.’s holdings, making the stock its 18th biggest position. Xponance Inc.’s holdings in UnitedHealth Group were worth $73,742,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on UNH shares. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 2.1 %

UNH opened at $499.01 on Tuesday. The stock has a market cap of $456.45 billion, a price-to-earnings ratio of 32.19, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50 day moving average price is $511.11 and its 200-day moving average price is $549.15. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm earned $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.